# IQVIA Holdings Inc. – Consensus ‘buy’ rating and 23.6% Upside Potential

- Link: https://www.directorstalkinterviews.com/iqvia-holdings-inc.consensus-buy-rating-and-23.6-upside-potential/4121132287
- Published: 2023-11-09T13:24:44+00:00
- Author: Charlotte Edwards

**IQVIA Holdings Inc.** with ticker code (IQV) have now 18 analysts in total covering
the stock. The consensus rating is pointing to ‘buy’. The target price High/Low 
ranges between $281.00 and $205.00 calculating the mean target price we have $247.22.
Given that the stocks previous close was at $200.08 this indicates there is a potential
upside of 23.6%. There is a 50 day moving average of $200.33 and the 200 day moving
average is $207.52. The company has a market capitalization of 36.46B. The stock
price is currently at: $199.76 USD

 The potential market cap would be $45,045,488,330 based on the market consensus.

The company has a dividend yield of 2.93%. Other points of data to note are a P/
E ratio of 33.57, revenue per share of $80.44 and a 4.9% return on assets.

IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions
and clinical research services to the life sciences industry. The Company operates
through three segments: Technology & Analytics Solutions, Research & Development
Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions
segment provides critical information, technology solutions and real-world insights
and services to the Company’s life science clients. The Research & Development Solutions
segment primarily serves biopharmaceutical customers, providing outsourced clinical
research and clinical trial related services. The Contract Sales & Medical Solutions
segment provides health care provider, including contract sales and patient engagement
services to both biopharmaceutical clients and the broader healthcare market. The
Company protects individual patient privacy. The Company conducts business in more
than 100 countries.

Share on: